Insider Buying: Valeant Pharmaceuticals Intl Inc (TSE:VRX) Insider Purchases 15,000 Shares of Stock

Valeant Pharmaceuticals Intl Inc (TSE:VRX) (NYSE:VRX) insider Paul Herendeen purchased 15,000 shares of Valeant Pharmaceuticals Intl stock in a transaction dated Tuesday, March 13th. The shares were bought at an average price of C$16.10 per share, with a total value of C$241,500.00.

Shares of VRX stock traded up C$0.32 during trading on Wednesday, hitting C$21.20. The company had a trading volume of 879,956 shares, compared to its average volume of 1,759,728. Valeant Pharmaceuticals Intl Inc has a 1 year low of C$11.20 and a 1 year high of C$30.56. The firm has a market cap of $7,690.00, a P/E ratio of 3.99 and a beta of -0.76.

TRADEMARK VIOLATION NOTICE: “Insider Buying: Valeant Pharmaceuticals Intl Inc (TSE:VRX) Insider Purchases 15,000 Shares of Stock” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at

About Valeant Pharmaceuticals Intl

Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.

Receive News & Ratings for Valeant Pharmaceuticals Intl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals Intl and related companies with's FREE daily email newsletter.

Leave a Reply